Giordano Botta: VA and Allelica Partner on Clinical Study of PRS and PGx in Cardiovascular Prevention
Giordano Botta, CEO and Co-Founder of Allelica, shared a post on LinkedIn:
“We are proud to partner with the U.S. Department of Veterans Affairs, the largest integrated healthcare system in the United States, on a randomized clinical trial evaluating the impact of polygenic risk score (PRS) and pharmacogenomics (PGx) in routine care.
This comes at a pivotal moment, as the new 2026 ACC/AHA guidelines now include PRS as a risk enhancing factor.
The study will compare standard care with a genomic guided approach.
Patients in the intervention arm will receive the Allelica multi-ancestry PRS for coronary artery disease together with PGx testing for statin response, including SLCO1B1.
The objective is to assess whether integrating genetic risk and drug response can improve statin prescription, adherence, and ultimately cardiovascular outcomes.
We look forward to supporting this clinical trial, designed to generate prospective evidence on the clinical utility of integrating PRS and PGx into cardiovascular prevention, with the potential to inform implementation at scale across large healthcare systems.”
Stay updated with Hemostasis Today.
-
Sep 14, 2026, 06:36Patrick Badertscher: PVI With vs Without Posterior Wall Isolation in Persistent AF
-
Sep 14, 2026, 06:31Mona Ranade: Can Mechanical Thrombectomy Play a Role in Septic Thrombophlebitis?
-
Sep 14, 2026, 06:30Alexsander Santiago: Tranexamic Acid – Why Timing Matters in Critical Bleeding
-
Sep 14, 2026, 06:25Gevorg Yaghjyan: How Surgical Intelligence Is Transforming Operating Rooms
-
Sep 14, 2026, 04:43Christina (Tina) P.: Retinopathy Risk With Long-Term HCQ Treatment Detailed in Meta-Analysis
-
Sep 14, 2026, 04:38Aravind Palraj: Uncovering the Drivers of Occlusive Retinal Vasculitis in Young Patients
-
Sep 14, 2026, 04:33Mostafa Elshazly: ERS Has just Relesed 2026 Update on the Treatment of PAH
-
Sep 14, 2026, 04:24Sourabh Dwivedi: Important Hemoglobinopathies – High-Yield-Alert!
-
Sep 14, 2026, 04:14Leonard Valentino: Deeply Grateful to be Nominated for the 2026 Galien Patient First Award